Company news & events

"There are three core strengths that separate Third Rock – the experience of its people, the innovation of the science its pursuing with its portfolio companies and the firm's ability to think big to address some of the most challenging diseases and conditions. Combined, these strengths give Third Rock the capability to help develop new treatments that will have a dramatic and significant impact on patients' lives."

Charles Homcy, M.D.
Venture Partner at Third Rock Ventures

 

 

September 21, 2011 - Keith Dionne Joins Third Rock Ventures as Entrepreneur-in-Residence

 

 

Portfolio news & events

Allena Pharmaceuticals
February 14, 2012 - Allena Pharmaceuticals Appoints Gino Santini to Board of Directors
» Press Release | Company News

 

NinePoint Medical
February 1, 2012 - NinePoint Medical Announces Formation of Clinical and Technology Advisory Boards
» Press Release | Company News

 

Foundation Medicine
February 1, 2012 - Foundation Medicine Recieves CLIA Certification for Its Genomic Sequencing Laboratory
» Press Release | Company News

 

Blueprint Medicines
January 24, 2012 - Blueprint Medicines Appoints Oncology Drug Development Leader Christoph Lengauer as Chief Scientific Officer
» Press Release | Company News

 

Constellation Pharma
January 17, 2012 - Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration
» Press Release | Company News

 

Ember Therapeutics

January 12, 2012 - Ember Therapeutics Announces Nature Publication of Brown Fat Biology Data; Program Exclusively Licensed from the Dana-Farber Cancer Institute
» Press Release | Company News

 

Foundation Medicine
January 10, 2012 - Foundation Medicine Announces Collaboration with Sanofi
» Press Release | Company News

 

WarpDrive Bio
January 10, 2012 - Third Rock Ventures and Sanofi Announce Launch of

Warp Drive Bio; Broad Strategic Partnership Builds Innovative Genomics Search Engine to Reveal Nature’s Drugs
» Press Release

 

NinePoint Medical
January 5, 2012 - NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
» Press Release | Company News

 

Seventh Sense Biosystems
December 16, 2011 - Seventh Sense Biosystems Receives $3.28 Million Grand Challenges Point-of-Care Diagnostics Grant to Expand Touch Activated Phlebotomy™ Technology Platform
» Press Release | Company News

 

Ember Therapeutics

December 15, 2011 - Third Rock Ventures Launches Ember Therapeutics to Address Critical Need for Novel Treatments for Metabolic Disease
» Press Release | Company News


Rhythm

November 30, 2011 - Rhythm Names Lex Van der Ploeg Chief Scientific Officer
» Press Release | Company News

 

Sage Therapeutics

November 30, 2011 - SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
» Press Release | Company News


TARIS Biomedical

November 30, 2011 - TARIS Initiates Phase 2 Clinical Study with LiRIS in Interstitial Cytitis Patients
» Press Release | Company News

Agios Pharmaceuticals
November 17, 2011 - Agios Secures $78 Million in Oversubscribed Series C Financing
» Press Release | Company News

 

Allena

November 16, 2011 - Allena Pharmaceuticals Launches with $15 Million Series A Round

» Press Release | Company News

 

Rhythm

November 9, 2011 - Rhythm Names Keith M. Gottesdiener Chief Executive Officer

» Press Release | Company News